B27PD

National Eye Institute (NEI) · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	B27PD
Also known as	Optiquel®
Sponsor	National Eye Institute (NEI)
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

B27PD CI brief — competitive landscape report
B27PD updates RSS · CI watch RSS
National Eye Institute (NEI) portfolio CI